Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

85.32 +0.28 (+0.33%)
Streaming Delayed Price Updated: 12:26 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Inari Medical Stock Gets RS Rating Upgrade ↗
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
Via Investor's Business Daily
News headline image
Novocure Stock Earns 96 RS Rating ↗
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73. 
Via Investor's Business Daily
News headline image
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year ↗
ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth. 
Via Investor's Business Daily
News headline image
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular ↗
 
Via Benzinga
News headline image
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular ↗
 
Via Benzinga
News headline image
Navigating 4 Analyst Ratings For LeMaitre Vascular ↗
 
Via Benzinga
News headline image
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024 ↗
LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Staar Surgical Stock Earns RS Rating Upgrade ↗
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
News headline image
Stryker Stock Sees RS Rating Treks Higher To 71 ↗
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. 
Via Investor's Business Daily
News headline image
Sell In May And Go Away? – April Dividend Income Report ↗
The “Sell in May and Go Away” adage is wrong for most investors. 
Via Talk Markets
News headline image
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 ↗
LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 ↗
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78. 
Via Investor's Business Daily
News headline image
Recap: LeMaitre Vascular Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2024 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
News headline image
A Preview Of LeMaitre Vascular's Earnings ↗
 
Via Benzinga
News headline image
5 Analysts Have This to Say About LeMaitre Vascular ↗
 
Via Benzinga
News headline image
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Sidoti Events, LLC's Virtual December Small-Cap Conference
Via ACCESSWIRE
News headline image
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating ↗
Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a  
Via Benzinga
News headline image
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock ↗
The healthcare company's dividend has soared in recent years. 
Via The Motley Fool
News headline image
2 Healthcare Stocks That Could Help Make You a Fortune ↗
These companies did well for shareholders over the last 10 years and have the potential to keep the growth going. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗
 
Via Benzinga
News headline image
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year ↗
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 ↗
 
Via Benzinga
News headline image
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday ↗
Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in... 
Via Benzinga
News headline image
3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential ↗
The smallest stocks have been trailing their larger counterparts. Here are three top micro-cap stocks to ride the asset class' resurgence. 
Via InvestorPlace
News headline image
Beat the Dow Jones With This Unstoppable Dividend Stock ↗
The wealth created by this medical devices company for its investors over the past decade far exceeds what the Dow Jones generated. 
Via The Motley Fool
News headline image
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.